OCGN
Price
$1.41
Change
-$0.06 (-4.08%)
Updated
Jul 13 closing price
Capitalization
479.01M
17 days until earnings call
Intraday BUY SELL Signals
SXTP
Price
$1.45
Change
-$0.11 (-7.05%)
Updated
Jul 13 closing price
Capitalization
3.86M
36 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

OCGN vs SXTP

OCGN vs SXTP Comparison Chart in %
View a ticker or compare two or three
VS
OCGN vs. SXTP commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OCGN is a StrongBuy and SXTP is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 14, 2026
Stock price -- (OCGN: $1.41 vs. SXTP: $1.45)
Brand notoriety: OCGN and SXTP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: OCGN: 48% vs. SXTP: 51%
Market capitalization -- OCGN: $479.01M vs. SXTP: $3.86M
OCGN [@Biotechnology] is valued at $479.01M. SXTP’s [@Biotechnology] market capitalization is $3.86M. The market cap for tickers in the [@Biotechnology] industry ranges from $121.89B to $0. The average market capitalization across the [@Biotechnology] industry is $2.13B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

OCGN’s FA Score shows that 0 FA rating(s) are green whileSXTP’s FA Score has 0 green FA rating(s).

  • OCGN’s FA Score: 0 green, 5 red.
  • SXTP’s FA Score: 0 green, 5 red.
According to our system of comparison, OCGN is a better buy in the long-term than SXTP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

OCGN’s TA Score shows that 5 TA indicator(s) are bullish while SXTP’s TA Score has 5 bullish TA indicator(s).

  • OCGN’s TA Score: 5 bullish, 5 bearish.
  • SXTP’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, SXTP is a better buy in the short-term than OCGN.

Price Growth

OCGN (@Biotechnology) experienced а -5.37% price change this week, while SXTP (@Biotechnology) price change was -13.69% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.21%. For the same industry, the average monthly price growth was +7.25%, and the average quarterly price growth was +1806.27%.

Reported Earning Dates

OCGN is expected to report earnings on Jul 31, 2026.

SXTP is expected to report earnings on Aug 19, 2026.

Industries' Descriptions

@Biotechnology (-3.21% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
OCGN($479M) has a higher market cap than SXTP($3.86M). OCGN YTD gains are higher at: 4.444 vs. SXTP (-28.684). SXTP has higher annual earnings (EBITDA): -7.48M vs. OCGN (-64.04M). OCGN has more cash in the bank: 31.9M vs. SXTP (3.34M). SXTP has less debt than OCGN: SXTP (152K) vs OCGN (33.3M). OCGN has higher revenues than SXTP: OCGN (4.47M) vs SXTP (1M).
OCGNSXTPOCGN / SXTP
Capitalization479M3.86M12,422%
EBITDA-64.04M-7.48M856%
Gain YTD4.444-28.684-15%
P/E RatioN/A14.57-
Revenue4.47M1M445%
Total Cash31.9M3.34M956%
Total Debt33.3M152K21,908%
FUNDAMENTALS RATINGS
OCGN: Fundamental Ratings
OCGN
OUTLOOK RATING
1..100
44
VALUATION
overvalued / fair valued / undervalued
1..100
83
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
46
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
OCGNSXTP
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
87%
Bullish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bullish Trend 1 day ago
87%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
82%
Advances
ODDS (%)
Bullish Trend 20 days ago
80%
Bullish Trend 22 days ago
82%
Declines
ODDS (%)
N/A
Bearish Trend 12 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
86%
Bullish Trend 1 day ago
87%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
OCGN
Daily Signal:
Gain/Loss:
SXTP
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IRSAX14.98N/A
N/A
Nomura Real Estate Securities A
PIDIX15.34N/A
N/A
Principal International EQ Index Instl
UGMVX11.88N/A
N/A
Victory Global Managed Volatility
JHQTX21.67N/A
N/A
JPMorgan Hedged Equity 3 I
FCGSX33.61N/A
N/A
Fidelity Series Growth Company

OCGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, OCGN has been loosely correlated with RAIN. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if OCGN jumps, then RAIN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OCGN
1D Price
Change %
OCGN100%
-4.08%
RAIN - OCGN
53%
Loosely correlated
-9.31%
ARRY - OCGN
47%
Loosely correlated
-3.92%
AXON - OCGN
46%
Loosely correlated
-3.32%
BEAM - OCGN
40%
Loosely correlated
-5.14%
QSI - OCGN
38%
Loosely correlated
-1.52%
More

SXTP and

Correlation & Price change

A.I.dvisor tells us that SXTP and OCGN have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SXTP and OCGN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SXTP
1D Price
Change %
SXTP100%
-7.05%
OCGN - SXTP
31%
Poorly correlated
-4.08%
ACXP - SXTP
30%
Poorly correlated
+5.33%
CABA - SXTP
26%
Poorly correlated
-7.06%
KROS - SXTP
26%
Poorly correlated
-5.93%
DNLI - SXTP
25%
Poorly correlated
+3.12%
More